Feasibility of ESWT Treatment in Post-stroke Patients With Triceps Sural Spasticity
NCT ID: NCT05255549
Last Updated: 2025-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2021-07-22
2022-07-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Secondary objectives: to compare functional performances in these two groups of patients receiving the different rehabilitation protocol with ESWT, using the following parameters:
\- Six Minutes walking test (6MWT) ; - Time Up \& Go (TUG); - Modified Ashworth scale (MAS); - Lower Extremity Functional Scale (LEFS); - passive ankle range of motion (p-ROM), pain (NRS); and presence of ankle clonus. These parameters are assessed during baseline (T0), after 4 weeks (T1) and after 12 weeks (T2).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of a Self-rehabilitation Program in Addition to Usual Treatment for Spasticity on Impairment and Activity Limitation in Patients With Spastic Hemiparesis Following Stroke
NCT02944929
Examining the Effectiveness of Combined Rehabilitation and Botulinum Toxin Injection on Functional Improvement of the Upper Limb After Stroke
NCT01511796
Efficacy Study of FES Controlled by Electromyographic Signal for the Treatment of Upper Limb in Post-stroke Patients
NCT03019744
The Kinesio-taping for the Prevention of Painful Shoulder and for the Functional Recovery of Upper Limb After Stroke
NCT05156164
Repetitive Arm Training + FES on Upper Extremity Motor Recovery in Sub-acute Stroke Survivors
NCT02267798
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I
ESWT + Stretching
3 weeks intervention:
* 3 sessions of ESWT, once a week
* 6 sessions of passive stretching, twice a week
Group II
ESWT and SHAM + Stretching
3 weeks intervention:
* 1 sessions of ESWT + 2 sessions of Sham, once a week
* 6 sessions of passive stretching, twice a week
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ESWT + Stretching
3 weeks intervention:
* 3 sessions of ESWT, once a week
* 6 sessions of passive stretching, twice a week
ESWT and SHAM + Stretching
3 weeks intervention:
* 1 sessions of ESWT + 2 sessions of Sham, once a week
* 6 sessions of passive stretching, twice a week
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Time elapsed since the stroke between 6 and 60 months
* Autonomous or supervised walking with or without aids
* Spasticity of the sural triceps\> 1 on the MAS scale
Exclusion Criteria
* Conditions that interfere with evaluation or collaboration in rehabilitation treatment (major psychiatric illnesses, clearly detectable cognitive deficits, severe pre-existing disabilities, sensory disturbances, etc.)
* Focal antispasmodic toxin treatments in the previous 3 months or phenolic blocks in the previous 9 months in the treatment region
* Treatments with central antispasmodic drugs with dosage modifications in the last week of starting treatment
* Individual neurorehabilitation treatments in progress
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda USL Reggio Emilia - IRCCS
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stefania Testoni, Dr
Role: PRINCIPAL_INVESTIGATOR
Azienda AUSLRE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Operational Unit of Physical Medicine and Rehabilitation AUSL - IRCCS Reggio Emilia
Reggio Emilia, Emilia-Romagna, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
31032021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.